Company profile
Fifty 1 Labs, Inc.
OTC: FITY · Healthcare · Drug Manufacturers - Specialty & Generic
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 34
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ Altman-Z, workforce scale
Methodology →Revenue TTM
$148
Rev growth YoY (TTM)
-99.9%
Net income (FY)
—
Employees
2
as of 2026-09-26
Market cap
$57.2k
as of 2026-09-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Fifty 1 Labs, Inc.’s financial profile?
Fifty 1 Labs, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Patient Access Solutions, Inc.——CDT Equity Inc.——Vincerx Pharma, Inc.——Adastra Holdings Ltd.——North Springs Resources Corp——Parallel Industries Inc.——Neighbors
Clark →Key facts
CEOJoel Gagnier
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLas Vegas, NV
ExchangeOTC: FITY
Employees2
IPO date2005-07-18
Latest filings
No filings loaded.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.